ESTRO 2020 Abstract book

ESTRO 2020 Abstract book content

DAY 1

Teaching Lecture The ultimate truth on how to get your paper published in an ESTRO journal .............................................................. (Abs. 1-4) Differential biological effects of photon and particle irradiation: experimental highlights and clinical impact ........ (Abs. 5) Fractionation in prostate cancer radiotherapy .................................................................................................................. (Abs. 6) Which organs should be spared to achieve optimal dose distribution in thoracic tumours? ......................................(Abs. 7) Do’s and don’ts in automated treatment planning – optimising conditions and expectations ................................... (Abs. 8) IAEA guide on Radiation Protection and Safety in Medical Uses of Ionising Radiation .................................................(Abs. 9) The evolution of RTT leadership in radiation oncology .....................................................................................................(Abs. 10) Symposium Management of complex skin targets-what is the optimal radiation technique? ......................................................... (Abs. 11-14) Cutting-edge genomics in radiation oncology .................................................................................................................... (Abs. 15-18) Debate This house believes that Elective nodal radiotherapy should be performed for high risk prostate cancer ...............(Abs. 19-22) This house believes that upfront radiotherapy is mandatory in patients with brain mets even in the era of immunotherapy ................................................................................................................................................................. (Abs. 23-26) Symposium Where automation can or cannot help the medical physicist ..........................................................................................(Abs. 27-29) Joint Symposium ESTRO-AAPM: The future of Medical Physics in Radiation Oncology .............................................................................. (Abs. 30-34) Symposium RTT leadership in radiation oncology .................................................................................................................................. (Abs. 35-37) Poster Highlights Poster highlights 1 CL: Head & Neck ....................................................................................................................................(Abs. 38-44) Poster highlights 2 PH: Dosimetry and detectors .............................................................................................................. (Abs. 45-50) Poster discussion CL: Head and neck 1 .............................................................................................................................................................. (Abs. 51-55) CL: Prostate 1 ..........................................................................................................................................................................(Abs. 56-61) Radiobiology ........................................................................................................................................................................... (Abs. 62-67) RTT 1 ........................................................................................................................................................................................ (Abs. 68-73) Proffered Papers Proffered papers 1: HSR HERO .............................................................................................................................................(Abs. 74-79) Proffered papers 2: Interactions between radiation and the immune response .......................................................... (Abs. 80-85) Proffered papers 3: Sarcoma ................................................................................................................................................(Abs. 86-90) Proffered papers 4: CNS ........................................................................................................................................................(Abs. 91-95) Proffered papers 5: Analysis for toxicity and outcome ..................................................................................................... (Abs. 96-101) Proffered papers 6: Novel treatment planning strategies ................................................................................................ (Abs. 102-107) Proffered papers 7: Evaluating and predicting toxicity in RT ............................................................................................(Abs. 108-113) Poster Highlights Poster highlights 3 CL : Prostate ...........................................................................................................................................(Abs. 114-120) Poster highlights 4 PH: Intrafractional motion ................................................................................................................... (Abs. 121-127) Presidential Symposium Presidential symposium: Translating research and partnership into optimal health ...................................................(Abs. 128-131)